Comments on: Who Should Buy Wyeth? How About Pfizer? http://www.pharmalot.com/2007/08/who-should-buy-wyeth-how-about-pfizer/ News, Comment and Conversation Fri, 10 Feb 2012 18:58:54 +0000 http://wordpress.org/?v=2.6.2 By: Andrew Smith http://www.pharmalot.com/2007/08/who-should-buy-wyeth-how-about-pfizer/#comment-17500 Andrew Smith Wed, 22 Aug 2007 18:44:53 +0000 http://www.pharmalot.com/2007/08/who-should-buy-wyeth-how-about-pfizer/#comment-17500 Besides being one of the only pharmaceutical companies that could possibly come up with the capital, and the lack of overlap between the two. The business connectioins between the two companies could also have an impact of this deal pushing through. Newsvisual has an interesting article on this. http://www.newsvisual.com/newsvisual/2007/08/click-here-to-v.html There isn't a much better time to buy than now with the stock price so low. Besides being one of the only pharmaceutical companies that could possibly come up with the capital, and the lack of overlap between the two. The business connectioins between the two companies could also have an impact of this deal pushing through. Newsvisual has an interesting article on this. http://www.newsvisual.com/newsvisual/2007/08/click-here-to-v.html

There isn’t a much better time to buy than now with the stock price so low.

]]> By: Slightly outside the box http://www.pharmalot.com/2007/08/who-should-buy-wyeth-how-about-pfizer/#comment-17441 Slightly outside the box Tue, 21 Aug 2007 19:06:34 +0000 http://www.pharmalot.com/2007/08/who-should-buy-wyeth-how-about-pfizer/#comment-17441 The premise of this proposed acquisition is that Pfizer want to continue to try and solve their problems with old-style thinking. Is there anything in Wyeth's recent history that suggests that their ability to get products through development to market is significantly better than anyone else? Does PFE really want to go through the massive integration issues as a stop-gap? If you read the PFE media releases it is pretty clear that they think they've got the biologics and vaccines on the way, Pristiq already has some question marks, Wyeth Alzheimer's output is hardly stellar. I just don't see Pfizer doing it. Having said that, there are a few others that could give it much closer consideration....... The premise of this proposed acquisition is that Pfizer want to continue to try and solve their problems with old-style thinking. Is there anything in Wyeth’s recent history that suggests that their ability to get products through development to market is significantly better than anyone else? Does PFE really want to go through the massive integration issues as a stop-gap?

If you read the PFE media releases it is pretty clear that they think they’ve got the biologics and vaccines on the way, Pristiq already has some question marks, Wyeth Alzheimer’s output is hardly stellar.

I just don’t see Pfizer doing it. Having said that, there are a few others that could give it much closer consideration…….

]]>